| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |